J. Horev

发表

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells

I. Tsarfaty, G. Woude, J. Resau, 2000, Oncogene.

Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI

Gil Navon, Ilan Tsarfaty, G. Navon, 2013, Scientific Reports.

Met Kinetic Signature Derived from the Response to HGF/SF in a Cellular Model Predicts Breast Cancer Patient Survival

R. Sharan, E. Ruppin, N. Yosef, 2012, PloS one.

Alteration of Met protooncogene product expression and prognosis in breast carcinomas.

I. Bièche, W. Alvord, G. V. Vande Woude, 1999, Analytical and quantitative cytology and histology.

Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice

I. Tsarfaty, J. Resau, J. Horev, 2016, PloS one.

Human epithelial tumor antigen cDNA sequences

R. Lathe, I. Tsarfaty, J. Horev, 1990 .

Molecular Analysis of H23 Epithelial Tumor Antigen - Differentially Spliced Full Length cDNAs and Gene

R. Lathe, C. Hart, I. Tsarfaty, 1991 .

A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue.

R. Lathe, I. Tsarfaty, J. Horev, 1990, European journal of biochemistry.

H23 Monoclonal Antibody Recognizes a Breast Tumor Associated Antigen: Clinical and Molecular Studies

I. Tsarfaty, J. Horev, A. Hizi, 1989 .

Isolation and characterization of an expressed hypervariable gene coding for a breast-cancer-associated antigen.

R. Lathe, I. Tsarfaty, J. Horev, 1990, Gene.

Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.

I. Tsarfaty, J. Horev, G. Tsarfaty, 2006, Cancer research.

Altering Met-HGF / SF Signaling Pathways Met-HGF / SF-Induced Scattering and Tumorigenicity by Mimp , a Mitochondrial Carrier Homologue , Inhibits

I. Tsarfaty, J. Horev, G. Tsarfaty, 2006 .

In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors.

Y. Itzchak, T. Kushnir, I. Tsarfaty, 2001, Cancer research.

Factor Receptor Activity in Normal Organs and Breast Tumors Molecular Imaging of Met Tyrosine Kinase Growth In Vivo

Y. Itzchak, T. Kushnir, I. Tsarfaty, 2001 .

A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway

Ilan Tsarfaty, Z. Levine, L. Dassa, 2008, Clinical Cancer Research.

Isolation and characterization of full length cDNA coding for the H23 breast tumor associated antigen

R. Lathe, I. Tsarfaty, J. Horev, 1989 .

Cell Motility Dynamics: A Novel Segmentation Algorithm to Quantify Multi-Cellular Bright Field Microscopy Images

Lior Wolf, Eshel Ben-Jacob, Inbal Hecht, 2011, PloS one.

Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms.

R. Lathe, I. Tsarfaty, J. Horev, 1990, European journal of biochemistry.

Interplay Between HGF/SF–Met-Ras Signaling, Tumor Metabolism and Blood Flow as a Potential Target for Breast Cancer Therapy

Sari Natan, I. Tsarfaty, J. Horev, 2013, Oncoscience.

A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway

I. Tsarfaty, J. Horev, Dalit Landesman-Milo, 2008, Clinical Cancer Research.